“…(GPHF) Minilab manual [4] or U.S. Food and Drug Administration Compendium of Unofficial Methods for Rapid Screening of Pharmaceuticals by Thin Layer Chromatography [5] to quantitative highperformance TLC (HPTLC)-densitometry methods. The model process was applied earlier to formulations containing acetylsalicylic acid, acetaminophen, ibuprofen, and chlorpheniramine maleate [1]; mebendazole, diphenhydramine HCl, amodiaquine, and artesunate [2]; amodiaqine and diazepam [3]; lumefantrine + artemether [6]; albendazole, amodiaquine + artesunate [7]; pyrazinamide + ethambutol + isoniazid + rifampicin [8]; quinine sulfate, mefloquine, and dihydroartemisinin + piperaquine phosphate [9]; azithromycin, imipramine HCl, and sulfadoxine + pyrimethamine [10]; clarithromycin, azithromycin, and amodiaquine + artesunate [11]; and cefixime, cefuroxime axetil, cephalexin hydrate, ciprofloxacin HCl, levofloxacin, and metronidazole [12].…”